Clinical trialNCT03084796CompletedPhase 2Interventional

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

SponsorChiesi Farmaceutici S.p.A.Enrollment733COPDChronic Obstructive Pulmonary Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the dose-response of different doses of CHF 5259 pMDI on lung function and other clinical outcomes, to identify the optimal dose(s) in terms of benefit/ risk ratio for further development in the target subject population.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Edward Kerwin, MD
Crisor LLC c/o Clinical Research Institute of Southern Oregon, Inc.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

112 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Chiesi Investigational Site
Birmingham, Alabama, United States
Chiesi Investigational Site
Dothan, Alabama, United States
Chiesi Investigational Site
Montgomery, Alabama, United States
Chiesi Investigational Site
Flagstaff, Arizona, United States
Chiesi Investigational Site
Glendale, Arizona, United States
Chiesi Investigational Site
Phoenix, Arizona, United States
Chiesi Investigational Site
Phoenix, Arizona, United States
Chiesi Investigational Site
Phoenix, Arizona, United States
Chiesi Investigational Site
Surprise, Arizona, United States
Chiesi Investigational Site
Tempe, Arizona, United States
Chiesi Investigational Site
Tucson, Arizona, United States
Chiesi Investigational Site
Anaheim, California, United States
Chiesi Investigational Site
Escondido, California, United States
Chiesi Investigational Site
Fullerton, California, United States
Clinical Trials Research
Lincoln, California, United States
Chiesi Investigational Site
Long Beach, California, United States
Chiesi Investigational Site
Los Angeles, California, United States
Chiesi Investigational Site
Los Angeles, California, United States
Chiesi Investigational Site
Los Angeles, California, United States
Chiesi Investigational Site
Newport Beach, California, United States
Chiesi Investigational Site
San Diego, California, United States
Chiesi Investigational Site
Tustin, California, United States
Chiesi Investigational Site
Westminster, California, United States
Chiesi Investigational Site
Boulder, Colorado, United States
Chiesi Investigational Site
Centennial, Colorado, United States
Chiesi Investigational Site
Denver, Colorado, United States
Chiesi Investigational Site
Lafayette, Colorado, United States
Chiesi Investigational Site
Brandon, Florida, United States
Chiesi Investigational Site
Clearwater, Florida, United States
Chiesi Investigational Site
Daytona Beach, Florida, United States
Chiesi Investigational Site
Edgewater, Florida, United States
Chiesi Investigational Site
Hialeah, Florida, United States
Chiesi Investigational Site
Kissimmee, Florida, United States
Chiesi Investigational Site
Miami, Florida, United States
Chiesi Investigational Site
Miami, Florida, United States
Chiesi Investigational Site
Miami, Florida, United States
Chiesi Investigational Site
Miami, Florida, United States
Chiesi Investigational Site
Orlando, Florida, United States
Chiesi Investigational Site
Panama City, Florida, United States
Chiesi Investigational Site
Blue Ridge, Georgia, United States

72 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CHF 5259PlaceboTiotropium Bromide 18 µg Inhalation Capsule

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Jul 2017
Primary completion: 23 May 2018
Completion: 6 Jun 2018
Last update posted: 15 Jun 2021
Registered enrollment: 733
Registry id: NCT03084796

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.